NCT01705548View on ClinicalTrials.gov

Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 24, 2012

Primary Completion Date

April 11, 2023

Study Completion Date

September 18, 2023

Conditions
Metastatic Malignant Neoplasm to BrainUnspecified Adult Solid Tumor, Protocol Specific
Interventions
RADIATION

Hypofractionated Radiosurgery

Radiation Therapy will consist of partial brain irradiation delivered to the metastatic brain tumor or resection cavity, delivered in 5 treatments with 2-3 treatments delivered per week.

Trial Locations (2)

30322

Emory University Hospital/Winship Cancer Institute, Atlanta

30342

Emory Saint Joseph's Hospital, Atlanta

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Emory University

OTHER

NCT01705548 - Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis | Biotech Hunter | Biotech Hunter